Tag: T-DM1

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to T-DM1

Around the Practice: Relapsed/Refractory HER2+ Metastatic Breast Cancer

Added to Collection on: 2021-04-22 15:56:15

Tags for this article:

Clinical medicine
Cancer treatments
Medicine
Antineoplastic drugs
Immunology
Trastuzumab emtansine
Breast cancer
Pertuzumab
HER2/neu
Trastuzumab
Metastatic breast cancer
Antibody-drug conjugate
Docetaxel
Paclitaxel
T-DM1
Capecitabine

Click the tags to see associated articles and topics

View Article Details
KATHERINE and FeDeriCa Trials Shift Standards in Early-Stage HER2+ Breast Cancer

Added to Collection on: 2021-05-06 16:16:53

Tags for this article:

Clinical medicine
Medicine
Drugs
Cancer treatments
Antineoplastic drugs
Trastuzumab emtansine
Immunology
Combination drugs
Trastuzumab
Pertuzumab
Breast cancer management
Genentech
T-DM1

Click the tags to see associated articles and topics

View Article Details
Adding checkpoint inhibition to anti-HER2 breast cancer therapy brings no benefit

Added to Collection on: 2021-06-17 17:26:15

Tags for this article:

Clinical medicine
Drugs
Cancer treatments
Breakthrough therapy
Orphan drugs
Monoclonal antibodies
Antineoplastic drugs
Atezolizumab
Pertuzumab
Triple-negative breast cancer
Trastuzumab emtansine
Trastuzumab
Switzerland
T-DM1

Click the tags to see associated articles and topics

View Article Details
ENHERTU® (fam-trastuzumab deruxtecan-nxki) significantly improved progression-free survival in ...

Added to Collection on: 2021-08-09 13:07:30

Tags for this article:

Clinical medicine
Cancer treatments
Cancer
Antibody-drug conjugates
Breakthrough therapy
Immunology
Antineoplastic drugs
Trastuzumab emtansine
HER2/neu
Trastuzumab
Breast cancer
Protein kinase inhibitor
T-DM1
Japan
United States
Daiichi Sankyo Company Limited
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Global HER2+ breast cancer ADC market to reach $3.3bn by 2030 - Pharmaceutical Technology

Added to Collection on: 2021-09-08 09:20:08

Tags for this article:

Clinical medicine
Cancer treatments
Medicine
Immunology
Antibody-drug conjugates
Antineoplastic drugs
Antibody-drug conjugate
Biotechnology
Trastuzumab emtansine
Trastuzumab
Seagen
HER2/neu
T-DM1

Click the tags to see associated articles and topics

View Article Details
Trastuzumab Deruxtecan Granted Priority Review From FDA for HER2-Positive Metastatic ...

Added to Collection on: 2022-01-17 17:01:33

Tags for this article:

Clinical medicine
Life Sciences
Cancer treatments
Antibody-drug conjugates
Trastuzumab emtansine
Immunology
Antineoplastic drugs
Trastuzumab deruxtecan
Trastuzumab
HER2/neu
Breast cancer
Daiichi Sankyo
United States
T-DM1

Click the tags to see associated articles and topics

View Article Details
Enhertu Delays Progression of HER2-Low and Ultralow Metastatic Breast Cancer

Added to Collection on: 2024-06-03 12:39:04

Tags for this article:

Breast cancer
Antineoplastic drugs
Antibody-drug conjugates
Immunology
Orphan drugs
Trastuzumab emtansine
Trastuzumab
Pertuzumab
Triple-negative breast cancer
Antibody-drug conjugate
Metastatic breast cancer
CDK inhibitor
T-DM1

Click the tags to see associated articles and topics

View Article Details